Efficacy and Safety of ACH24 in the Treatment of Vitiligo
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a multicenter clinical trial, phase III, randomized, placebo-controlled, parallel
group, enroll 94 patients, to assess the efficacy of ACH24 in the repigmentation of
achromatic areas in patients with vitiligo.